Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Market Cap	3.99B
Revenue (ttm)	2.31B
Net Income (ttm)	513.05M
Shares Out	14.93M
EPS (ttm)	34.35
PE Ratio	7.78
Forward PE	n/a
Dividend	16.74 (6.26%)
Ex-Dividend Date	Nov 12, 2025

Volume	3,436
Average Volume	4,049
Open	268.81
Previous Close	268.81
Day's Range	267.18 - 269.80
52-Week Range	83.10 - 315.00
Beta	0.11
RSI	50.96
Earnings Date	Feb 12, 2026

About EGX:CPCI

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya. Kahira Pharmaceuticals & Chemical Industries Company was founded in 1962 and is headquartered in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,760
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In 2025, EGX:CPCI's revenue was 2.08 billion, an increase of 52.80% compared to the previous year's 1.36 billion. Earnings were 443.72 million, an increase of 80.29%.